Publication Name	World Journal of Clinical Cases
Manuscript ID	93811
Country	South Korea

Received	2024-03-18 05:48
Peer-Review Started	2024-03-18 05:48
To Make the First Decision
Return for Revision	2024-05-02 12:53
Revised	2024-05-03 04:59
Second Decision	2024-05-22 02:45
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-05-22 10:44
Articles in Press	2024-05-22 10:44
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-05-31 08:48
Publish the Manuscript Online	2024-06-29 10:30

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Clinical and Translational Research
Article Title	Efficacy of fexuprazan compared with rebamipide in Korean patients with gastritis: A matching-adjusted indirect comparison
Manuscript Source	Unsolicited Manuscript
All Author List	Gwang Ha Kim and Hang Lak Lee
ORCID	Author(s) ORCID Number Gwang Ha Kim http://orcid.org/0000-0001-9721-5734 Hang Lak Lee http://orcid.org/0000-0002-2825-3216
Funding Agency and Grant Number
Corresponding Author	Gwang Ha Kim, MD, PhD, Professor, Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan 49241, South Korea. doc0224@pusan.ac.kr
Key Words	Gastritis; Erosive gastritis; Fexuprazan; Rebamipide; Matching-adjusted indirect comparison; Indirect treatment comparison
Core Tip	In a matching-adjusted indirect comparison, the effectiveness of fexuprazan, a novel potassium-competitive acid blocker, was compared with that of rebamipide, one of the most commonly used mucoprotective agents for acute and chronic gastritis in a real-world setting in South Korea. We conclude that a two-week fexuprazan treatment is superior to a two-week rebamipide treatment and similar to a four-week rebamipide treatment for patients with gastritis.
Publish Date	2024-06-29 10:30
Citation	<p>Kim GH, Lee HL. Efficacy of fexuprazan compared with rebamipide in Korean patients with gastritis: A matching-adjusted indirect comparison. <i>World J Clin Cases</i> 2024; 12(19): 3890-3897</p>
URL	https://www.wjgnet.com/2307-8960/full/v12/i19/3890.htm
DOI	https://dx.doi.org/10.12998/wjcc.v12.i19.3890

Full Article (PDF)	WJCC-12-3890-with-cover.pdf
PRISMA 2009 Checklist	93811-PRISMA-2009-Checklist.pdf
Manuscript File	93811_Auto_Edited-LJH-JLW.docx
Answering Reviewers	93811-answering-reviewers.pdf
Audio Core Tip	93811-audio.m4a
Biostatistics Review Certificate	93811-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form	93811-conflict-of-interest-statement.pdf
Copyright License Agreement	93811-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	93811-non-native-speakers.pdf
Supplementary Material	93811-supplementary-material.pdf
Peer-review Report	93811-peer-reviews.pdf
Scientific Misconduct Check	93811-scientific-misconduct-check.png
Scientific Misconduct Check	93811-scientific-misconduct-check.png
Scientific Editor Work List	93811-scientific-editor-work-list.pdf
CrossCheck Report	93811-crosscheck-report.pdf